CD 129 Pill - brown capsule/oblong, 15mm
Pill with imprint CD 129 is Brown, Capsule/Oblong and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Dr. Reddy’s Laboratories Inc.
Ranitidine is used in the treatment of GERD; Cutaneous Mastocytosis; Duodenal Ulcer; Duodenal Ulcer Prophylaxis; Erosive Esophagitis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CD 129
Ranitidine Hydrochloride
- Imprint
- CD 129
- Strength
- 150 mg
- Color
- Brown
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Rx and/or OTC
- Drug Class
- H2 antagonists
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Dr. Reddy’s Laboratories Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
sodium starch glycolate type A potato,
ferrosoferric oxide,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
gelatin
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 55111-0129 (Discontinued) | Dr. Reddy's Laboratories, Inc. |
| 42291-0735 (Discontinued) | AvKare, Inc. |
More about ranitidine
- Check interactions
- Compare alternatives
- Reviews (163)
- Drug images
- Latest FDA alerts (18)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: H2 antagonists
- Breastfeeding
Patient resources
- Ranitidine drug information
- Ranitidine Tablets and Capsules
- Ranitidine Injection
- Ranitidine Suspension
- Ranitidine Syrup
Other brands
Professional resources
- Ranitidine prescribing information
- Ranitidine Capsule (FDA)
- Ranitidine Injection (FDA)
- Ranitidine Syrup (FDA)
- Ranitidine Tablets (FDA)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
